Microtubule Associated Protein Tau Expression as a Predictive and Prognostic Marker in a Trial Assessing Sequential Docetaxel as Adjuvant Chemotherapy for Early Breast Cancer (TACT). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Tutt, A
  • Gillett, C
  • Pinder, S
  • A'Hern, RP
  • Dowsett, M
  • Ellis, IO
  • Bartlett, J
  • Bliss, JM
  • Johnston, S
  • Ellis, Peter

publication date

  • December 15, 2009